Saralasin infusion in screening patients for renovascular hypertension
- 31 March 1980
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 45 (3) , 609-613
- https://doi.org/10.1016/s0002-9149(80)80012-9
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The immediate pressor response to saralasin in man: a test of angiotensin II receptor vacancy.Circulation Research, 1979
- Renin, Sodium, and Vasodepressor Response to Saralasin in Renovascular and Essential HypertensionAnnals of Internal Medicine, 1977
- Saralasin Infusion in the Recognition of Renovascular HypertensionAnnals of Internal Medicine, 1977
- Detection of Renovascular Hypertension with Angiotensin II BlockadeAnnals of Internal Medicine, 1977
- Measures of Clinical EfficacyNew England Journal of Medicine, 1975
- Use of an Angiotensin II Antagonist (Saralasin) in the Recognition of “Angiotensinogenic” HypertensionNew England Journal of Medicine, 1975
- INFUSION OF ANGIOTENSIN-II ANALOGUE IN TWO PATIENTS WITH UNILATERAL RENOVASCULAR HYPERTENSIONThe Lancet, 1974
- An Angiotensin Converting-Enzyme Inhibitor to Identify and Treat Vasoconstrictor and Volume Factors in Hypertensive PatientsNew England Journal of Medicine, 1974
- ANGIOTENSIN-II BLOCKADE IN MAN BY SAR1-ALA8-ANGIOTENSIN II FOR UNDERSTANDING AND TREATMENT OF HIGH BLOOD-PRESSUREThe Lancet, 1973
- Antihypertensive action of propranolol: Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertensionThe American Journal of Cardiology, 1973